Literature DB >> 22433344

Epidemiology of retained placenta: oxytocin as an independent risk factor.

Margit Endler1, Charlotta Grünewald, Sissel Saltvedt.   

Abstract

OBJECTIVE: To identify factors related to retained placenta in the context of contemporary obstetric practice.
METHODS: This was a case-control study comparing 408 cases of retained placenta and an equivalent number of control individuals. Epidemiological and delivery-related variables were registered in computerized prenatal and in-hospital medical records. Univariable and multivariable logistic regressions were used for estimation of risk ratios and statistical significance.
RESULTS: Independent risk factors for retained placenta were: previous retained placenta (odds ratio [OR] 12.61, 95% confidence interval [CI] 3.61-44.08); preterm delivery (OR 3.28, 95% CI 1.60-6.70); oxytocin use for 195-415 minutes (OR 2.00, 95% CI 1.20-3.34); oxytocin use more than 415 minutes (OR 6.55, 95% CI 3.42-12.54, number needed to harm 2.3); preeclampsia (OR 2.85, 95% CI 1.20-6.78); two or more previous miscarriages (OR 2.62, 95% CI 1.31-5.20); and one or more previous abortion (OR 1.58, 95% CI 1.09-2.28). Parity of two or more had a seemingly protective effect (OR 0.40, 95% CI 0.24-0.70), as did smoking at the start of pregnancy (OR 0.28, 95% CI 0.09-0.88). Retained placenta was significantly associated with an increased risk of postpartum hemorrhage. The OR related to blood loss exceeding 500 mL, 1,000 mL, and 2,000 mL and the need for blood transfusion was 33.07 (95% CI 20.57-53.16), 43.44 (95% CI 26.57-71.02), 111.24 (95% CI 27.26-454.00), and 37.48 (95% CI 13.63-103.03), respectively. Diabetes was numerically overrepresented in the case group, but the power of the study to detect a significant difference in risk outcome was insufficient.
CONCLUSION: Identifying risk factors for retained placenta is important in the assessment of women after delivery. The increased risk associated with duration of oxytocin use is of interest, considering its widespread use. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433344     DOI: 10.1097/AOG.0b013e31824acb3b

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Patterns of recurrence of postpartum hemorrhage in a large population-based cohort.

Authors:  Anna Sara Oberg; Sonia Hernandez-Diaz; Kristin Palmsten; Catarina Almqvist; Brian T Bateman
Journal:  Am J Obstet Gynecol       Date:  2013-10-26       Impact factor: 8.661

2.  Anaesthesia/analgesia for manual removal of retained placenta.

Authors:  Kiattisak Kongwattanakul; Nonthida Rojanapithayakorn; Malinee Laopaiboon; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2020-06-12

3.  Myomectomy for retained placenta due to incarcerated fibroid mass.

Authors:  S U Mbamara; Abc Daniyan; Ejenobo Osaro; I C Mbah
Journal:  Ann Med Health Sci Res       Date:  2015 Mar-Apr

4.  Oxidative stress and inflammation in retained placenta: a pilot study of protein and gene expression of GPX1 and NFκB.

Authors:  Margit Endler; Sissel Saltvedt; Mohamed Eweida; Helena Åkerud
Journal:  BMC Pregnancy Childbirth       Date:  2016-12-06       Impact factor: 3.007

5.  Retained placenta after vaginal delivery: risk factors and management.

Authors:  Nicola C Perlman; Daniela A Carusi
Journal:  Int J Womens Health       Date:  2019-10-07

6.  Risk factors for non-adherent retained placenta after vaginal delivery: a systematic review.

Authors:  Alessandro Favilli; Valentina Tosto; Margherita Ceccobelli; Fabio Parazzini; Massimo Franchi; Vittorio Bini; Sandro Gerli
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-31       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.